Filter
939
Filtered Results: 939
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
79
New Publications
285
Language
Document type
No document type
483
Studies & Reports
170
Guidelines
141
Manuals
57
Strategic & Response Plan
52
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
South Africa
24
Global
23
Liberia
21
Ghana
20
Nigeria
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Malawi
15
Bangladesh
15
Nepal
14
Western and Central Europe
14
Namibia
13
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Latin America and the Carribbean
4
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
415
Clinical Guidelines
58
Key Resources
36
Public Health
35
Pharmacy & Technologies
28
Women & Child Health
23
Capacity Building
3
Toolboxes
AMR
123
Pharmacy
118
COVID-19
54
HIV
39
TB
39
Rapid Response
34
Mental Health
31
Global Health Education
20
Planetary Health
19
Caregiver
14
NTDs
14
Conflict
14
Ebola & Marburg
13
Health Financing Toolbox
13
Specific Hazards
10
NCDs
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
Zika
2
Social Ethics
1
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
Prices people pay for medicines.
Malawi Internationally recommended key policies uptake
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Building on Nigeria’s Call to Action to Save Newborn Lives, the Federal Ministry of Health (FMoH) has developed the National Strategy and Implementation Plan for Scale-up of Chlorhexidine. The Ministry incorporated existing maternal, newborn, and child health plans with additional comprehensive st...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
